Damien Fink

Effects of teclistamab and talquetamab on soluble BCMA levels in patients with relapsed/refractory multiple myeloma

Suzette Girgis, Shun Xin Wang Lin, Kodandaram Pillarisetti et al. · Blood Advances · 2022 · 49 citations · Full text

Medicine, Hematology, Pharmacology +14

Mechanistic Pharmacokinetic/Target Engagement/Pharmacodynamic (PK/TE/PD) Modeling in Deciphering Interplay Between a Monoclonal Antibody and Its Soluble Target in Cynomolgus Monkeys

Weirong Wang, Xiaofeng Wang, Rajitha Doddareddy et al. · The AAPS Journal · 2013 · 47 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

A novel C2 domain binding CD33xCD3 bispecific antibody with potent T-cell redirection activity against acute myeloid leukemia

Priyanka Nair-Gupta, Michael Diem, Dara Reeves et al. · Blood Advances · 2020 · 43 citations · Full text

Medicine, Immunology, Oncology +17

The first‐in‐human study of CNTO 7160, an anti‐interleukin‐33 receptor monoclonal antibody, in healthy subjects and patients with asthma or atopic dermatitis

Ivo Nnane, Bart Frederick, Zhenling Yao et al. · British Journal of Clinical Pharmacology · 2020 · 36 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15

Epidemiologic factors affecting antimicrobial resistance of common bacterial isolates

Paul D. Ellner, Damien Fink, Harold C. Neu et al. · Journal of Clinical Microbiology · 1987 · 32 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17